Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: S9630, Medroxyprogesterone in Treating Women With Breast Cancer [Phase 3]
Phase 3 study (S9630) evaluating medroxyprogesterone for treatment of breast cancer in women; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
Pfizer tested Aromasin (exemestane) as adjuvant therapy in postmenopausal women with invasive estrogen receptor-positive early breast cancer…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive [Phase 1]
Phase 1 study of SU011248 in combination with docetaxel and trastuzumab in advanced HER-2 positive breast cancer; results posted.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer [NA]
A completed clinical trial evaluating the use of breast ultrasound and mammography for screening in women at high risk for breast cancer.
-
CLINICAL_TRIALS withdrawal · 2012-10-29Clinical Trial Update: Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating PF-04691502 in combination with exemestane versus exemestane alone for advanced breast cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer [Phase 2]
A Phase 2 breast cancer trial evaluating combination chemotherapy followed by peripheral stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression [Phase 2]
Phase 2 trial evaluating Polyphenon E (green tea extract) and its effect on breast cancer progression has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the safety, efficacy, and pharmacokinetics of combining capecitabine with exisulind in metastatic brea…
-
CLINICAL_TRIALS withdrawal · 2012-10-24Clinical Trial Update: A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy, trastuzumab, and RAD001 (everolimus) for HER2-positive breast cancer ha…
-
CLINICAL_TRIALS research · 2012-10-24Clinical Trial Update: 18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound [NA]
This document provides an update on a clinical trial evaluating the 18F-FLT PET imaging tracer for suspicious findings on mammography and br…
-
CLINICAL_TRIALS research · 2012-10-23Clinical Trial Update: Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial is evaluating the effects of Chinese medical treatment on chemotherapy-induced leucopenia in breast cancer patients…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Telephone-Based Decision Support for Rural Patients [NA]
A completed clinical trial from UCSF evaluated telephone-based decision support for rural breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating DLBS1425 in advanced/metastatic breast cancer has been terminated. The update discusses observed efficacy and safet…
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors [Phase 2]
A Phase 2 trial evaluated amifostine for treating paclitaxel-induced peripheral neuropathy in patients with solid tumors; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer [Phase 3]
A Phase 3 non-inferiority trial compares two filgrastim preparations for preventing neutropenia in breast cancer; the study status is comple…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Brain Metastases In ErbB2-Positive Breast Cancer [Phase 2]
Phase 2 trial of lapatinib for ErbB2-positive breast cancer with brain metastases was terminated, with results posted in 2012.
-
CLINICAL_TRIALS research · 2012-10-15Clinical Trial Update: Evaluation of Attitudes About Fertility
This clinical trial update evaluates attitudes about fertility among breast cancer patients. No trial results or regulatory actions are repo…
-
CLINICAL_TRIALS research · 2012-10-12Clinical Trial Update: BCRL Prevention Pilot
This is an update on a completed pilot clinical trial focused on preventing breast cancer–related lymphedema (BCRL), sponsored by the Abrams…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" [Phase 3]
A Phase 3 trial (DELTA STUDY) evaluating decongestive lymphatic therapy for lymphedema in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer [Phase 2]
Phase II study evaluating a tailored-dose docetaxel regimen in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer [Phase 2]
This update reports the completion of a Phase II trial evaluating tailored-dose docetaxel in combination with trastuzumab for HER2-positive …
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
This clinical trial update reports that the study predicting response to neoadjuvant chemotherapy in women with operable breast cancer has b…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors [NA]
A completed clinical trial update examining T-cell responses in HER2-positive solid tumors treated with trastuzumab and/or chemotherapy. The…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing docetaxel monotherapy to DOXIL plus docetaxel in patients with advanced breast cancer; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: Multi-centre Clinical Trial on Hormone Replacement Treatment in China [Phase 4]
A Phase 4, multi-centre clinical trial in China evaluating hormone replacement therapy for menopausal symptoms with associated cardiovascula…